153 related articles for article (PubMed ID: 1150041)
1. Toxicity of chenodeoxycholic acid in the rhesus monkey.
Dyrszka H; Chen T; Salen G; Mosbach EH
Gastroenterology; 1975 Aug; 69(2):333-7. PubMed ID: 1150041
[TBL] [Abstract][Full Text] [Related]
2. Hepatic toxicity in the rhesus monkey treated with chenodeoxycholic acid for 6 months: biochemical and ultrastructural studies.
Dyrszka H; Salen G; Zaki FG; Chen T; Mosbach EH
Gastroenterology; 1976 Jan; 70(1):93-104. PubMed ID: 812760
[TBL] [Abstract][Full Text] [Related]
3. Influence of primary bile acid feeding on cholesterol metabolism and hepatic function in the rhesus monkey.
Webster KH; Lancaster MC; Hofmann AF; Wease DF; Baggenstoss AH
Mayo Clin Proc; 1975 Mar; 50(3):134-8. PubMed ID: 1117759
[TBL] [Abstract][Full Text] [Related]
4. Lack of toxicity of chenodeoxycholic acid in the squirrel monkey.
Suzuki H; Yoshida T; Miki H; Sado T; Hashimoto K
Gastroenterology; 1977 Aug; 73(2):310-3. PubMed ID: 406161
[TBL] [Abstract][Full Text] [Related]
5. Letter: Toxicity of chenodeoxycholic acid in rhesus monkeys.
Salen G; Dryszka H; Chen T; Salzman WH; Mosbach EH
Lancet; 1974 Dec; 2(7895):1517-8. PubMed ID: 4140430
[No Abstract] [Full Text] [Related]
6. Bile acids in bile during long-term chenodeoxycholic acid treatment.
Bremmelgaard A; Pedersen L
Scand J Gastroenterol; 1976; 11(2):161-5. PubMed ID: 1265436
[TBL] [Abstract][Full Text] [Related]
7. Effect of dietary chenodeoxycholic acid and lithocholic acid in the rabbit.
Fischer CD; Cooper NS; Rothschild MA; Mosbach EH
Am J Dig Dis; 1974 Oct; 19(10):877-86. PubMed ID: 4418483
[No Abstract] [Full Text] [Related]
8. Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.
Danzinger RC; Hofmann AF; Thistle JL; Schoenfield LJ
J Clin Invest; 1973 Nov; 52(11):2809-21. PubMed ID: 4583981
[TBL] [Abstract][Full Text] [Related]
9. [Non-sulfated bile acids in rat liver cells. Studies on the toxicity of chenedeoxycholic acid].
Kurtz W; Janka P; Swoboda L; Leuschner U
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():496-9. PubMed ID: 612015
[No Abstract] [Full Text] [Related]
10. Criteria for selection of patients for medical treatment (chenodeoxycholic acid therapy) of gallstones.
Bruusgaard A; Malver E; Pedersen LR; Schlichting P; Sylvest J
Scand J Gastroenterol; 1977; 12(1):97-102. PubMed ID: 834976
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects between ursodeoxycholic and chenodeoxycholic acids on liver function and structure and bile acid composition in the Rhesus Monkey.
Sarva RP; Fromm H; Farivar S; Sembrat RF; Mendelow H; Shinozuka H; Wolfson SK
Gastroenterology; 1980 Oct; 79(4):629-36. PubMed ID: 7409382
[TBL] [Abstract][Full Text] [Related]
12. Effect of high and low doses of ursodeoxycholic acid on gallstone dissolution in humans.
Salen G; Colalillo A; Verga D; Bagan E; Tint GS; Shefer S
Gastroenterology; 1980 Jun; 78(6):1412-8. PubMed ID: 7372061
[No Abstract] [Full Text] [Related]
13. Comparative formation of lithocholic acid from chenodeoxycholic and ursodeoxycholic acids in the colon.
Bazzoli F; Fromm H; Sarva RP; Sembrat RF; Ceryak S
Gastroenterology; 1982 Oct; 83(4):753-60. PubMed ID: 7106506
[TBL] [Abstract][Full Text] [Related]
14. Treatment of gallstones with chenodeoxycholic acid and phenobarbital.
Coyne MJ; Bonorris GG; Chung A; Goldstein LI; Lahana D; Schoenfield LJ
N Engl J Med; 1975 Mar; 292(12):604-7. PubMed ID: 1089875
[TBL] [Abstract][Full Text] [Related]
15. Semiquantitative measurement of lithocholic acid compounds in bile from patients with gallstones, before and during treatment with chenodeoxycholic acid.
Arnfred T; Pedersen L
Scand J Gastroenterol; 1976; 11(5):497-504. PubMed ID: 959764
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of ursodeoxycholic acid in man.
Fedorowski T; Salen G; Calallilo A; Tint GS; Mosbach EH; Hall JC
Gastroenterology; 1977 Nov; 73(5):1131-7. PubMed ID: 908492
[No Abstract] [Full Text] [Related]
17. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
19. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.
Stiehl A; Raedsch R; Czygan P; Götz R; Männer C; Walker S; Kommerell B
Gastroenterology; 1980 Dec; 79(6):1192-8. PubMed ID: 7439628
[TBL] [Abstract][Full Text] [Related]
20. Effect of 7-ketolithocholic acid on bile acid metabolism in humans.
Salen G; Verga D; Batta AK; Tint GS; Shefer S
Gastroenterology; 1982 Aug; 83(2):341-7. PubMed ID: 7084613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
